Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
07/2012
07/04/2012CN101716220B Shielding alkaloid traditional Chinese medicine
07/04/2012CN101687860B Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
07/04/2012CN101616896B Tricyclic compounds and their use as glucocorticoid receptor modulators
07/04/2012CN101597272B Sodium salt compound of Iguratimod, preparation method thereof and pharmaceutical use thereof
07/04/2012CN101591369B N-glycosyl-3-aryl acrylamide derivative, preparation method and medical function thereof
07/04/2012CN101585859B Novel scutellarin derivative as well as preparation method and pharmaceutical composition thereof
07/04/2012CN101574392B Prevention and treatment of diseases induced by microcirculation disturbance with total salvianolic acid
07/04/2012CN101524361B Process for preparing adenosine analogue and its application
07/04/2012CN101502571B Blood circulation-promoting, antalgic and anti-inflammatory medicament as well as preparation method and use thereof
07/04/2012CN101491536B Therapeutically useful synthetic oligonucleotides
07/04/2012CN101474262B Medicinal bath powder for dispelling wind and removing dampness
07/04/2012CN101416972B External medicine capable of preventing and treating cardiovascular disease and preparation method thereof
07/04/2012CN101401846B Bi-syndrome treating Chinese medicine preparation
07/04/2012CN101381418B Sterculia seed single polysaccharide SPA, preparation method and application thereof
07/04/2012CN101375834B Solid dispersion of Ailamode and preparation method thereof and medicament application
07/04/2012CN101347255B Kudzu root drink and preparation method and equipment
07/04/2012CN101279017B Yunnan hongyao extract and extracting method thereof and application
07/03/2012US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
07/03/2012US8211896 Aryl sulfonamides
07/03/2012US8211691 Transgenic methylotrophic yeast for use as bioreactors in production of heterologous polypeptides
07/03/2012US8211401 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA
07/03/2012CA2694227C Compositions and methods for treating or controlling anterior-segment inflammation
07/03/2012CA2640956C B7rp-1 polypeptides
07/03/2012CA2538405C Novel compounds
07/03/2012CA2509406C Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
07/03/2012CA2474894C Desaturase genes, enzymes encoded thereby, and uses thereof
07/03/2012CA2471041C Compositions and methods for enhancing corticosteriod delivery
07/03/2012CA2463814C Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
07/03/2012CA2406132C Ligand for herpes simplex virus entry mediator and methods of use
07/03/2012CA2370805C Ureas as cell adhesion modulators
07/03/2012CA2318052C Antibodies against human il-12
06/2012
06/28/2012WO2012088425A2 Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
06/28/2012WO2012088043A1 Enriched amaranthus blitoides compositions and uses
06/28/2012WO2012087782A1 Pyrazolopiperidine compounds as ccr1 receptor antagonists
06/28/2012WO2012087771A1 Novel imidazole-2-benzamide compounds useful for the treatment of osteoarthritis
06/28/2012WO2012087377A1 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
06/28/2012WO2012087160A2 Anti-inflammatory proteins and methods of preparation and use thereof
06/28/2012WO2012086184A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
06/28/2012WO2012085662A1 2-amino-4-arylthiazole compounds as trpa1 antagonists
06/28/2012WO2012085176A1 Tricyclic pyrazinone compounds, compositions and methods of use thereof as janus kinase inhibitors
06/28/2012WO2012084975A1 Novel multicomponent crystals made of ([2-amino-6-(4-fluoro-benzylamino)- pyridin-3-yl]-carbamic acid ethyl ester and 2-[2-[(2,6-dichlorphenyl)-amino]-phenyl]-acetic acid
06/28/2012WO2012060594A3 Anti-inflammatory composition containing a thiourea compound and a pharmaceutically acceptable salt thereof as an active ingredient
06/28/2012WO2012030170A3 Novel compound acting as a cannabinoid receptor-1 inhibitor
06/28/2012WO2012030137A3 Pharmaceutical composition for preventing or treating inflammatory diseases, allergic diseases or asthma, containing diospyros blancoi a. dc. extract as active ingredient
06/28/2012US20120165782 pharmaceutical composition of an iontophoresis
06/28/2012US20120165410 Production of encapsulated nanoparticles at high volume fractions
06/28/2012US20120165406 Bis-trifluoromethyl honokiol analogs and their use in treating cancers
06/28/2012US20120165404 Treatment of neurodegeneration and neuroinflammation
06/28/2012US20120165397 Chemical modification of short small hairpin rnas for inhibition of gene expression
06/28/2012US20120165382 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
06/28/2012US20120165380 Methods of treating alpha adrenergic mediated conditions
06/28/2012US20120165378 Thiophene-carboxamides useful as inhibitors of protein kinases
06/28/2012US20120165368 Pyrazolopyridine kinase inhibitors
06/28/2012US20120165367 Azaindazoles useful as inhibitors of kinases
06/28/2012US20120165366 Compounds and uses thereof
06/28/2012US20120165361 Drug coating providing high drug loading and methods for providing the same
06/28/2012US20120165359 Opioid Agonist/Antagonist Combinations
06/28/2012US20120165358 Controlled release formulations of opioid and nonopioid analgesics
06/28/2012US20120165357 Compositions Containing Berberine or Analogs Thereof for Treating Rosacea or Red Face Related Skin Disorders
06/28/2012US20120165338 New biaryl amide derivatives
06/28/2012US20120165332 Sulfonamides and sulfamides as zap-70 inhibitors
06/28/2012US20120165329 Compounds and methods for kinase modulation, and indications therefor
06/28/2012US20120165328 Inhibitors of b lymphocyte kinase
06/28/2012US20120165327 Spiropiperidines for use as tryptase inhibitors
06/28/2012US20120165326 Derivatives of 6-(6-substituted-triazolopyridazine-sulfanyl) 5-fluoro benzothiazoles and 5-fluoro benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
06/28/2012US20120165322 Rho kinase inhibitors
06/28/2012US20120165321 Quinoline derivatives as pi3 kinase inhibitors
06/28/2012US20120165319 Inhibitors of interleukin-1 beta converting enzyme
06/28/2012US20120165307 Azaindoles useful as inhibitors of janus kinases
06/28/2012US20120165306 Pyrazinylpyridines useful for the treatment of proliferative diseases
06/28/2012US20120165303 Triazolyl phenyl benzenesulfonamides
06/28/2012US20120165302 Antifungal formulations
06/28/2012US20120165300 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3
06/28/2012US20120165299 Combination medicament
06/28/2012US20120165298 Sulfonamide compounds
06/28/2012US20120165293 Synthesis of prostanoids
06/28/2012US20120165292 METHODS FOR TREATMENT OF MULTIPLE MYELOMA USING CYCLOPROPANE CARBOXYLIC ACID {2-(Is)-(3-eTHOXY-4METHOXY-PHENYL)-2-METHANESULFONYL-ETHYL}-3-OXO-2.3-DIHYDRO-1H-ISOINDOL-4-YL}-AMIDE
06/28/2012US20120165285 Combined preparation for use as a medicament
06/28/2012US20120165281 Stilbenoid derivatives and their uses
06/28/2012US20120165277 Novel galactoside inhibitors of galectins
06/28/2012US20120165258 Compositions and Methods for Treatment of Thrombosis and for Prolonging Survival of Stored Platelets
06/28/2012US20120165255 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
06/28/2012US20120165251 Diabetes therapy
06/28/2012US20120165244 Methods for binding lewis y antigen
06/28/2012US20120165243 Use of dietary fibres against muscle wasting
06/28/2012US20120164240 Enriched a. blitoides compositions and uses thereof
06/28/2012US20120164228 Novel pharmaceutical formulations to prevent the misuse of medicinal drugs
06/28/2012US20120164221 Combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night
06/28/2012US20120164213 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
06/28/2012US20120164209 Abuse resistant drugs, method of use and method of making
06/28/2012US20120164193 Extended-release formulation for reducing the frequency of urination and method of use thereof
06/28/2012US20120164192 Delayed release formulation for reducing the frequency of urination and method of use thereof
06/28/2012US20120164184 DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
06/28/2012US20120164174 Adjuvant composition containing poly-gamma-glutamic acid-chitosan nanoparticles
06/28/2012US20120164161 Antibodies and Uses Thereof
06/28/2012US20120164159 Humanised Antibodies to Toll-Like Receptor 2 and Uses Thereof
06/28/2012US20120164152 Anti-il-17f antibodies and methods of use thereof
06/28/2012US20120164139 Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders
06/28/2012US20120164138 Use of anti-cd1 antibodies for the modulation of immune responses
06/28/2012US20120164124 Phage-associated lytic enzymes for treatment of bacillus anthracis and related conditions
1 ... 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 ... 1272